Having established that MAGI2 downregulation seems to be a stereotypical reaction in glomerular disease models, we evaluated its protein level in immunofluorescence analysis as a possible marker for glomerular diseases (Fig. 12A). Here, MAGI2 is linked to glomerular disorder.